Incyte Corporation, a Delaware-based biopharmaceutical company, focuses on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology.

- New facility to serve as European base for Incyte’s drug development operations

- Location provides efficient access to key clinical trial experts and institutions
http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=2034738
Find an actor

4à6 - BioArk Visp AG, Lonza Ibex, Curio Biotech SA and Swissfillon AG20.09.2018

BioAlps’ "4à6" are a series of events organized in each of the 7 cantons of Western Switzerland.

Addex Pharma - recoit un financement de 1,2 M£

Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as part of the...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn